Nifty
:
24834.85
Sensex
:
81332.72
428.75 (1.76%)
1292.92 (1.62%)
Nifty
Sensex
:
:
24834.85
81332.72
428.75 (1.76%)
1292.92 (1.62%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
63/99

BSE: 531633 | NSE: LINCOLN

NSE BSE
654.35
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  672.45
  •  673.55
  •  652.00
  •  666.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  65603
  •  433.26
  •  755.15
  •  406.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,306.04
  • 14.00
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,293.28
  • 0.28%
  • 2.20

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.78%
  • 1.70%
  • 37.10%
  • FII
  • DII
  • Others
  • 3.95%
  • 0.00%
  • 7.47%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.26
  • 6.86
  • 6.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.09
  • 5.82
  • 0.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.21
  • 8.40
  • 5.41

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.45
  • 9.42
  • 10.84

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.70
  • 1.55
  • 1.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.16
  • 6.58
  • 7.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
142.49
112.46
26.70%
146.45
133.77
9.48%
155.99
140.61
10.94%
135.62
123.47
9.84%
Expenses
124.11
95.82
29.52%
116.79
107.01
9.14%
124.84
111.71
11.75%
114.90
106.56
7.83%
EBITDA
18.38
16.64
10.46%
29.66
26.75
10.88%
31.15
28.90
7.79%
20.72
16.91
22.53%
EBIDTM
12.90%
14.80%
20.25%
20.00%
19.97%
20.55%
15.28%
13.70%
Other Income
7.02
3.90
80.00%
11.02
6.36
73.27%
8.70
5.72
52.10%
7.69
6.50
18.31%
Interest
0.50
1.15
-56.52%
0.16
0.33
-51.52%
0.39
0.14
178.57%
0.42
0.41
2.44%
Depreciation
2.69
2.41
11.62%
2.81
2.26
24.34%
2.58
2.42
6.61%
2.54
2.07
22.71%
PBT
22.22
16.98
30.86%
37.71
30.52
23.56%
36.87
32.06
15.00%
25.45
20.93
21.60%
Tax
3.62
4.42
-18.10%
9.67
8.90
8.65%
9.21
8.35
10.30%
6.43
5.91
8.80%
PAT
18.60
12.56
48.09%
28.04
21.61
29.75%
27.65
23.71
16.62%
19.01
15.01
26.65%
PATM
13.05%
11.17%
19.15%
16.16%
17.73%
16.86%
14.02%
12.16%
EPS
9.28
6.27
48.01%
14.00
10.79
29.75%
13.81
11.84
16.64%
9.49
7.49
26.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
580.55
510.31
472.12
424.19
386.49
366.15
360.61
360.26
400.15
266.07
210.49
Net Sales Growth
13.76%
8.09%
11.30%
9.75%
5.56%
1.54%
0.10%
-9.97%
50.39%
26.41%
 
Cost Of Goods Sold
278.34
179.43
169.71
155.86
138.15
135.66
156.44
202.90
254.64
161.12
123.72
Gross Profit
302.21
330.88
302.41
268.32
248.34
230.49
204.18
157.35
145.50
104.96
86.77
GP Margin
52.06%
64.84%
64.05%
63.25%
64.26%
62.95%
56.62%
43.68%
36.36%
39.45%
41.22%
Total Expenditure
480.64
421.11
376.64
337.01
320.95
298.91
308.30
313.52
359.62
240.47
190.42
Power & Fuel Cost
-
10.25
8.33
7.10
8.18
7.21
6.82
5.92
5.68
4.27
3.40
% Of Sales
-
2.01%
1.76%
1.67%
2.12%
1.97%
1.89%
1.64%
1.42%
1.60%
1.62%
Employee Cost
-
93.16
79.72
63.26
58.65
51.90
51.15
37.59
28.83
17.87
18.57
% Of Sales
-
18.26%
16.89%
14.91%
15.18%
14.17%
14.18%
10.43%
7.20%
6.72%
8.82%
Manufacturing Exp.
-
85.72
69.33
61.54
64.05
60.71
51.73
29.44
35.81
25.98
19.10
% Of Sales
-
16.80%
14.68%
14.51%
16.57%
16.58%
14.35%
8.17%
8.95%
9.76%
9.07%
General & Admin Exp.
-
31.06
27.56
23.06
21.30
20.98
17.50
14.78
20.34
18.86
15.07
% Of Sales
-
6.09%
5.84%
5.44%
5.51%
5.73%
4.85%
4.10%
5.08%
7.09%
7.16%
Selling & Distn. Exp.
-
19.20
19.49
24.54
26.79
20.02
21.24
19.91
10.10
9.42
8.42
% Of Sales
-
3.76%
4.13%
5.79%
6.93%
5.47%
5.89%
5.53%
2.52%
3.54%
4.00%
Miscellaneous Exp.
-
2.28
2.51
1.64
3.83
2.43
3.44
2.97
4.22
2.95
8.42
% Of Sales
-
0.45%
0.53%
0.39%
0.99%
0.66%
0.95%
0.82%
1.05%
1.11%
1.01%
EBITDA
99.91
89.20
95.48
87.18
65.54
67.24
52.31
46.74
40.53
25.60
20.07
EBITDA Margin
17.21%
17.48%
20.22%
20.55%
16.96%
18.36%
14.51%
12.97%
10.13%
9.62%
9.53%
Other Income
34.43
22.47
10.00
5.66
11.04
5.63
5.45
2.78
7.36
7.19
2.49
Interest
1.47
2.03
1.45
1.56
2.02
4.00
5.41
6.66
9.96
8.38
6.97
Depreciation
10.62
9.17
8.09
7.56
7.33
6.68
6.11
5.51
4.87
4.57
3.53
PBT
122.25
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
19.85
12.07
Tax
28.93
27.58
26.58
21.47
15.77
13.46
11.60
9.20
9.27
4.80
1.89
Tax Rate
23.66%
27.45%
27.70%
25.65%
23.46%
21.64%
25.08%
24.65%
28.03%
24.18%
15.66%
PAT
93.30
72.90
69.36
62.25
51.44
48.71
34.62
28.12
23.68
15.01
10.65
PAT before Minority Interest
93.30
72.90
69.36
62.25
51.47
48.74
34.65
28.13
23.80
15.04
10.18
Minority Interest
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.01
-0.12
-0.03
0.47
PAT Margin
16.07%
14.29%
14.69%
14.68%
13.31%
13.30%
9.60%
7.81%
5.92%
5.64%
5.06%
PAT Growth
28.00%
5.10%
11.42%
21.01%
5.60%
40.70%
23.12%
18.75%
57.76%
40.94%
 
EPS
46.65
36.45
34.68
31.13
25.72
24.36
17.31
14.06
11.84
7.51
5.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
502.47
432.88
366.39
313.09
269.34
224.22
192.38
140.52
111.31
98.81
Share Capital
20.03
20.03
20.03
20.00
20.00
20.00
20.00
16.31
16.31
16.31
Total Reserves
482.44
412.85
346.36
293.09
249.34
204.22
172.38
116.65
95.00
82.50
Non-Current Liabilities
37.88
10.99
26.10
42.85
28.43
24.94
31.75
33.74
33.14
26.18
Secured Loans
0.00
0.00
0.14
0.85
1.69
6.93
12.38
23.62
15.27
16.20
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
10.21
3.04
Long Term Provisions
25.22
0.00
15.98
32.51
17.49
7.19
9.98
0.00
0.00
0.00
Current Liabilities
96.15
110.71
94.78
80.32
100.37
113.48
99.42
100.34
114.47
131.05
Trade Payables
51.15
71.67
57.07
51.24
44.01
43.42
32.46
30.38
45.31
66.51
Other Current Liabilities
14.22
9.84
13.43
9.13
11.11
11.11
12.77
15.10
11.52
14.15
Short Term Borrowings
2.00
2.04
0.00
3.83
30.09
48.55
45.04
52.62
50.67
48.46
Short Term Provisions
28.78
27.16
24.28
16.11
15.16
10.41
9.15
2.24
6.97
1.92
Total Liabilities
636.50
554.58
487.27
436.64
398.50
362.97
323.85
274.79
261.85
259.75
Net Block
150.53
131.88
110.64
122.72
120.91
116.58
102.71
98.47
65.62
65.07
Gross Block
197.47
171.07
141.90
146.70
138.11
127.65
108.16
120.89
87.50
82.22
Accumulated Depreciation
46.95
39.19
31.26
23.98
17.21
11.08
5.45
22.42
21.88
17.15
Non Current Assets
245.42
181.51
159.59
173.91
159.43
136.08
134.27
127.83
80.64
110.69
Capital Work in Progress
6.71
16.05
1.69
0.04
2.10
0.29
6.63
2.73
2.55
2.37
Non Current Investment
0.00
0.00
0.00
0.09
0.09
0.09
0.09
0.01
0.01
0.41
Long Term Loans & Adv.
87.71
31.83
46.81
51.02
36.01
18.79
24.48
26.62
12.47
42.84
Other Non Current Assets
0.47
1.75
0.45
0.03
0.33
0.34
0.36
0.00
0.00
0.00
Current Assets
391.08
373.07
327.69
262.73
239.08
226.88
189.58
146.98
181.20
149.06
Current Investments
91.33
96.81
80.66
34.22
18.07
10.97
10.25
0.00
0.00
0.00
Inventories
70.03
72.74
46.61
47.40
36.23
45.41
37.31
27.48
21.82
23.84
Sundry Debtors
136.33
115.94
113.35
101.34
122.47
109.44
90.67
80.53
119.01
89.04
Cash & Bank
34.32
18.80
13.84
14.58
7.58
14.59
11.68
12.66
11.51
10.45
Other Current Assets
59.08
1.19
1.43
1.11
54.74
46.47
39.68
26.31
28.86
25.73
Short Term Loans & Adv.
56.98
67.59
71.79
64.09
53.64
45.18
39.02
26.26
28.86
25.73
Net Current Assets
294.93
262.36
232.91
182.41
138.71
113.40
90.16
46.63
66.73
18.01
Total Assets
636.50
554.58
487.28
436.64
398.51
362.96
323.85
274.81
261.84
259.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
39.26
76.13
69.27
75.42
52.84
26.63
25.04
44.80
24.56
4.64
PBT
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
19.85
12.07
Adjustment
-0.23
1.48
4.84
8.66
9.30
11.64
10.70
13.75
10.68
12.75
Changes in Working Capital
-31.37
2.40
0.20
14.33
-1.12
-22.00
-13.24
4.80
-2.50
-17.56
Cash after chg. in Working capital
68.87
99.83
88.76
90.22
70.38
35.88
34.79
51.62
28.02
7.26
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-29.61
-23.70
-19.49
-14.81
-17.53
-9.25
-9.75
-6.82
-3.46
-2.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-36.64
-78.08
-64.23
-30.88
-18.19
-11.77
-25.48
-41.79
6.52
1.45
Net Fixed Assets
-17.06
-43.53
-35.54
-5.59
-11.52
-12.45
4.05
-29.04
-4.21
-0.95
Net Investments
5.48
-16.15
-20.70
-14.20
-7.10
-2.72
-16.01
-7.34
-1.43
0.00
Others
-25.06
-18.40
-7.99
-11.09
0.43
3.40
-13.52
-5.41
12.16
2.40
Cash from Financing Activity
-4.50
-2.56
-5.75
-37.76
-35.77
-11.41
0.30
-3.42
-32.04
-10.51
Net Cash Inflow / Outflow
-1.88
-4.50
-0.70
6.77
-1.11
3.45
-0.14
-0.41
-0.96
-4.42
Opening Cash & Equivalents
6.93
11.44
12.14
5.46
6.57
3.12
3.26
3.75
4.82
9.39
Closing Cash & Equivalent
5.05
6.93
11.44
12.23
5.46
6.57
3.12
3.43
3.87
4.97

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
250.86
216.12
182.92
156.54
134.67
112.11
96.19
81.52
68.24
60.58
ROA
12.24%
13.31%
13.48%
12.33%
12.80%
10.09%
9.40%
8.87%
5.77%
4.10%
ROE
15.59%
17.35%
18.32%
17.67%
19.75%
16.63%
17.29%
19.49%
14.32%
10.83%
ROCE
21.82%
24.29%
24.90%
22.30%
22.50%
19.05%
18.51%
21.18%
15.91%
11.48%
Fixed Asset Turnover
2.89
3.17
3.04
2.81
2.84
3.07
3.19
3.90
3.20
2.67
Receivable days
86.41
84.27
89.34
102.22
112.23
100.99
85.52
89.69
139.97
139.16
Inventory Days
48.90
43.86
39.12
38.19
39.51
41.74
32.36
22.16
30.72
36.67
Payable days
124.92
138.44
126.82
56.60
57.26
47.62
37.21
40.22
92.31
115.76
Cash Conversion Cycle
10.40
-10.30
1.64
83.82
94.48
95.11
80.67
71.63
78.37
60.06
Total Debt/Equity
0.00
0.00
0.00
0.02
0.12
0.27
0.34
0.59
0.69
0.69
Interest Cover
50.50
67.11
54.61
34.32
16.56
9.55
6.60
4.32
3.37
2.73

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Lincoln Pharma - Quarterly Results
    16th May 2024, 12:14 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.